TATAELXSI Tata Elxsi Q4 FY26 results (Jan–Mar 2026) and concall
Tata Elxsi reported a mixed Q4 FY26, with modest constant currency revenue growth of 0.9% QoQ to INR 993.8 crores, driven by strong performance in Media & Communication (5.6% QoQ CC) and new deal wins in Transportation (0.2% QoQ CC). However, the Healthcare & Life Sciences vertical saw a significant de-growth of 13.1% QoQ CC due to deal delays. The company achieved a healthy EBITDA margin of 24.6%, an improvement of 130 bps sequentially, attributed to operational efficiencies and currency tailwinds. Management revised its overall FY27 growth outlook to a high-single digit, acknowledging ongoin
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 9.5%, net profit up 27.9% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 939 | 908 | 892 | 918 | 953 +1% | 994 +9% |
| EBITDA | 247 | 208 | 187 | 193 | 222 −10% | 245 +18% |
| Net profit | 199 | 172 | 144 | 155 | 109 −45% | 220 +28% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
